αB-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain
Dmitry Malin(Northwestern University), Vincent L. Cryns(University of Wisconsin–Madison), Bárbara Adamo(Hospital Clínic de Barcelona), Carey K. Anders(Duke University), Eric V. Shusta(University of Wisconsin–Madison), C. Ryan Miller(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Chad Livasy(University of North Carolina at Chapel Hill), Karen Fritchie(University of North Carolina at Chapel Hill), Elena Strekalova(Northwestern University), Andrey Ugolkov(Fate Therapeutics (United States)), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Matt Ewend(Northwestern University), Vladimír Petrovič(Northwestern University), Abraham Al Ahmad(Northwestern University), Joseph Geradts(East Carolina University), Kimberly Blackwell(Duke University), Erika Hamilton(Sarah Cannon)
Cited by 100
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k